Parkinson Disease
📧 Sign up to get email alerts when something new happens for Parkinson Disease.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2009-05-04Clinical Trial Update: Treadmill Training and Quality of Life in Parkinson's Disease [NA]
The clinical trial evaluating treadmill training and its impact on quality of life in Parkinson's disease has completed.
-
FDA approval · 2009-04-29FDA Approved: AMANTADINE HYDROCHLORIDE — Supplemental Application (PAI Holdings, LLC dba PAI Pharma)
FDA approved a supplemental application for amantadine hydrochloride from PAI Pharma, resulting in labeling changes to the product.
-
CLINICAL_TRIALS trial_result · 2009-04-27Clinical Trial Update: Different Dyskinesias in Parkinson's Disease and Their Relation to Levodopa Pharmacokinetics [Phase 4]
A completed Phase 4 trial examining different forms of dyskinesia in Parkinson's disease and their relationship to levodopa pharmacokinetics…
-
CLINICAL_TRIALS trial_result · 2009-04-13Clinical Trial Update: Pilot Randomized Controlled Trial of Telemedicine for Individuals With Parkinson Disease in a Rural Population
A pilot randomized controlled trial evaluated telemedicine for individuals with Parkinson disease in a rural population; the study status is…
-
EMA withdrawal · 2009-03-10Orion Corporation withdraws its application for an extension of indication for Stalevo (levodopa/carbidopa/entacapone)
Orion Corporation has withdrawn its application to extend the indication for Stalevo (levodopa/carbidopa/entacapone).
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2009-02-25Clinical Trial Update: SEDPARK2: Post Marketing Surveillance to Observe Safety and Efficacy of Piribedil in Parkinson's Disease (PIR-002/K)
Post-marketing surveillance study of piribedil (PIR-002/K) in Parkinson's disease to monitor safety and efficacy; the study has completed.
-
CLINICAL_TRIALS trial_result · 2009-02-16Clinical Trial Update: Botulinum Toxin Type A (Botox) in the Management of Levodopa-Induced Peak-Dose Dyskinesias in Parkinson's Disease [Phase 4]
The Phase 4 clinical trial investigating botulinum toxin type A (Botox) for levodopa-induced peak-dose dyskinesias in Parkinson's disease ha…
-
FDA approval · 2009-02-09FDA Approved: TASMAR — Supplemental Application (Bausch Health US LLC)
The FDA approved a supplemental application for TASMAR (tolcapone) submitted by Bausch Health US LLC.
-
FDA label_change · 2009-02-09FDA Approved: AMANTADINE HYDROCHLORIDE — Supplemental Application (Upsher-Smith Laboratories, LLC)
The FDA approved Upsher-Smith Laboratories' supplemental application for Amantadine Hydrochloride.
-
FDA approval · 2009-02-09FDA Approved: AMANTADINE HYDROCHLORIDE — Supplemental Application (Upsher-Smith Laboratories, LLC)
FDA approved a supplemental application for amantadine hydrochloride submitted by Upsher-Smith Laboratories, LLC.
-
CLINICAL_TRIALS trial_result · 2009-02-06Clinical Trial Update: An Open Label SLV308 Safety Extension to Study S308.3.003 in Early PD Patients [Phase 3]
This document reports an open-label safety extension of SLV308 in early Parkinson's disease as part of the S308.3.003 Phase 3 trial. The stu…
-
CLINICAL_TRIALS research · 2009-02-05Clinical Trial Update: Effects of Deep Brain Stimulation for the Treatment of Parkinson's Disease
A clinical trial evaluating deep brain stimulation as a treatment for Parkinson's disease has completed.
-
FDA approval · 2009-02-02FDA Approved: CARBIDOPA, LEVODOPA, AND ENTACAPONE — Supplemental Application (Sandoz Inc)
The FDA approved a supplemental application for Sandoz's carbidopa/levodopa/entacapone product, expanding its labeling for use in Parkinson …
-
FDA label_change · 2009-02-02FDA Approved: ENTACAPONE — Supplemental Application (Sun Pharmaceutical Industries, Inc.)
The FDA approved Sun Pharmaceutical Industries' supplemental application for entacapone, resulting in updated labeling for the product.
-
CLINICAL_TRIALS trial_result · 2009-01-30Clinical Trial Update: Ascending Dose Tolerability/Safety of SLV308 for the Treatment of Parkinson's Disease [Phase 3]
Phase 3 trial updating ascending-dose tolerability and safety data for SLV308 in Parkinson's disease has completed.
-
CLINICAL_TRIALS trial_result · 2009-01-26Clinical Trial Update: An Open Label SLV308 Safety Extension to Study S308.3.001 in Early PD Patients [Phase 3]
This records the completion of an open-label safety extension of SLV308 in early-stage Parkinson's disease within a Phase 3 program.
-
CLINICAL_TRIALS research · 2009-01-21Clinical Trial Update: Incidence of Parkinson's Disease Among Veterans
A US Department of Veterans Affairs–sponsored clinical trial assessing the incidence of Parkinson's disease among veterans has completed.
-
CLINICAL_TRIALS trial_result · 2009-01-19Clinical Trial Update: Coenzyme Q10 as a Symptomatic Treatment in Parkinson's Disease [Phase 3]
A Phase 3 clinical trial evaluating Coenzyme Q10 as a symptomatic treatment for Parkinson's disease has completed. The update notes completi…
-
CLINICAL_TRIALS research · 2009-01-15Clinical Trial Update: Botulinum A Toxin in Patients With Parkinson's Disease [Phase 4]
Phase 4 clinical trial update evaluating botulinum toxin type A in patients with Parkinson's disease and related conditions; trial status is…
-
CLINICAL_TRIALS trial_result · 2009-01-14Clinical Trial Update: Efficacy, Safety, and Pharmacokinetics/Pharmacodynamic Study of L-Dopa/Carbidopa To Treat Parkinson's Disease [Phase 2]
Phase 2 study evaluating the efficacy, safety, and pharmacokinetics/pharmacodynamics of levodopa-carbidopa in Parkinson's disease has comple…
-
CLINICAL_TRIALS trial_result · 2009-01-09Clinical Trial Update: Dose-Finding Safety Study of BIIB014 in Early-Stage Parkinson's Disease [Phase 2]
A Phase 2 dose-finding safety study of BIIB014 in early-stage Parkinson's disease has completed.
-
CLINICAL_TRIALS research · 2009-01-05Clinical Trial Update: Far Infrared Irradiation for Management and Treating of Parkinson's Disease (PD) [Phase 1]
A Phase 1 clinical trial evaluating far infrared irradiation for Parkinson's disease; the current status is unknown.
-
FDA label_change · 2008-12-31FDA Approved: ZELAPAR — Supplemental Application (Bausch Health US, LLC)
The FDA approved a supplemental application for Zelapar (selegiline hydrochloride) filed by Bausch Health US, LLC, indicating changes to the…
-
FDA approval · 2008-12-31FDA Approved: SINEMET — Supplemental Application (Organon LLC)
The FDA approved a supplemental application for Sinemet (carbidopa/levodopa) submitted by Organon LLC.
-
CLINICAL_TRIALS research · 2008-12-31Clinical Trial Update: A Randomised Controlled Trial (RCT) to Evaluate Use of an Individual Auditory Cueing Device's (IACD's) on Freezing and Gait in People With Parkinson's Disease (PD) [Phase 1, Phase 2]
This entry describes a phase 1/2 randomized trial evaluating an Individual Auditory Cueing Device to improve freezing and gait in Parkinson'…